Cardiovascular Devices Market worth $110.39 billion by 2029

The report " Cardiovascular Devices Market by Product (Cardiac Imaging, Rhythm Management, Cardiac Assist Devices, Interventional Cardiology, Electrophysiology, Monitoring ), Indication (CAD, MI, CHF), End User (Hospitals & Clinics) - Global Forecast to 2029" , is USD 77.71 billion in 2024 and is projected to reach USD 110.39 billion by 2029, at a CAGR of 7.3% during the forecast period. Browse 459 market data Tables and 57 Figures spread through 428 Pages and in-depth TOC on "Cardiovascular Devices Market by Product (Cardiac Imaging, Rhythm Management, Cardiac Assist Devices, Interventional Cardiology, Electrophysiology, Monitoring ), Indication (CAD, MI, CHF), End User (Hospitals & Clinics) - Global Forecast to 2029" Download PDF- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72205881 The cardiovascular devices market is growth-driven by a few factors, which include the high prevalence of cardiovascular diseases, increased preference for minimally invasive procedures, and advancement in medical technology. Cardiovascular diseases are one of the leading causes of deaths worldwide, monitoring and and interventional devices are, are highly in demand. “Based on product type, the cardiac rhythm management devices segment to the second largest share” Cardiac rhythm management (CRM) devices are designed to regulate and monitor the hearts electrical activity, aiding to correct abnormal heart rhythms (arrhythmias). These devices are used to treat diseases such as bradycardia , tachycardia, and heart failure by ensuring that the heart beats at a normal pace and rhythm. Leadless devices are more beneficial to the patients and enhance their safety. Therefore, its adoption rate is high as compared to traditional CRM devices, which often come with leads and thus prone to infections and mechanical failures. The leadless devices are also MRI-safe therefore highly adopted these days as MRI procedures are frequently required for patients suffering from other chronic conditions. Moreover, the growing older population and unhealthy lifestyle patterns have led to an increased number of cases for arrhythmia, further stimulating the growth in demand for CRM technologies. The adoption of these next-generation CRM devices by the population with the view of establishing itself in the market has resulted from technological innovation coupled with the prevalence of arrhythmia. “The congestive heart failure segment is expected to hold a significant share, by indication segment in the cardiovascular devices market.” Congestive heart failure is a chronic and progressive condition in which the heart cannot pump blood to meet the body's needs. Inefficiency may be due to several underlying heart conditions, such as coronary artery disease, high blood pressure, or cardiomyopathy, which weaken the heart muscle or impair its ability to fill properly. CHF affects millions of the world's population, and is increasingly prevalent due to aging, sedentary lifestyle, and comorbidities such as obesity, hypertension, and diabetes. This condition has high medical demands. This requires advanced diagnostics and therapeutic solutions. Management of CHF requires various cardiovascular devices, that includes implantable cardiac defibrillator, CRT devices, LVADs, and remote monitoring systems. These devices improve survival and also enhance the quality of life by reducing hospitalization thereby, effectively managing symptoms.Therefore, healthcare providers are increasingly adopting innovative cardiovascular technologies which is further bolstered by favorable reimbursement policies and strong R&D investments. CHF is still a leading cause of cardiovascular morbidity and mortality, its increasing prevalence ensures steady demand for advanced cardiovascular devices. “Based on end user, the ambulatory surgical centers account for the highest CAGR during the forecast period in cardiovascular devices market.” Interventional cardiology procedures using various devices s...